This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2024!
9-12 April 2024Messe Wien Congress Centre, Vienna

Ulrich Ruemenapp
Head of Launch Preparation at Bayer AG
Speaker

Profile

Dr. Rümenapp is based in Wuppertal, Germany and working within the Bayer Pharmaceuticals, Product Supply Biotech organization, where he is responsible for product development of late stage assets and launch preparations including the transfer of Bayer’s pipeline candidates (proteins, antibodies and antibody-drug-conjugates) to external manufacturing partners as well as strategic projects.

Prior to that, Dr. Rümenapp worked in Biologics Development, and he was Head of Projects in Bayer Biotech Contract Manufacturing, where he was responsible for contract manufacturing partnerships for biotech drug substances and drug products and interdisciplinary project management to ensure market supply.

Before it was acquired by Bayer, Dr. Rümenapp hold a similar position at Schering AG, and he started his career in the Production & Logistics department of Schering, where he was responsible for production aspects of licensing deals, due diligences, and product acquisitions of small molecule products and biologics.

Dr. Rümenapp studied chemistry and holds a Ph.D. in biosciences. He worked several years in academic biosciences research and as an assistant teacher in general pharmacology.

To correspond with Dr. Rümenapp, please contact him at: ulrich.ruemenapp@bayer.com

Agenda Sessions

  • Strategic outsourcing of biologics CMC development and manufacturing

    11:00